• 2008

Company Description

Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.

Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.